School of Pharmacy

Publications in the Biomolecular Science and Medicinal Chemistry Division

Publications

Content
NUTLEY, B.P., RAYNAUD, F.I., WILSON, S.C., FISCHER, P.M., HAYES, A., GODDARD, P.M., MCCLUE, S.J., JARMAN, M., LANE, D.P. and WORKMAN, P., 2005. Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse. Molecular Cancer Therapeutics. 4(1), 125-139

Content
UHRINOVA, S., UHRIN, D., POWERS, H., WATT, K., ZHELEVA, D., FISCHER, P.M., MCINNES, C. and BARLOW, P.N., 2005. Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding. Journal of Molecular Biology. 350(3), 587-598

Content
DEKKER, LODEWIJK V, DANIELS, ZOE, HICK, CAROLINE, ELSEGOOD, KATHRYN, BOWDEN, SARAH, SZESTAK, TADGE, BURLEY, J RUSSELL, SOUTHAN, ANDY, CRONK, DAVID and JAMES, IAIN F, 2005. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells. European Journal of Pharmacology. 528(1-3), 52-8

Content
BROWN, SEAN G, THOMAS, ALISON, DEKKER, LODEWIJK V, TINKER, ANDREW and LEANEY, JOANNE L, 2005. PKC-delta sensitizes Kir3.1/3.2 channels to changes in membrane phospholipid levels after M3 receptor activation in HEK-293 cells. American Journal of Physiology: Cell Physiology. 289(3), C543-56

Content
RENAULT, MARIE-ANGE, JALVY, SANDRA, POTIER, MYLèNE, BELLOC, ISABELLE, GENOT, ELISABETH, DEKKER, LODEWIJK V, DESGRANGES, CLAUDE and GADEAU, ALAIN-PIERRE, 2005. UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. Journal of Biological Chemistry. 280(4), 2708-13

Content
DEKKER,L.V. and CRONK,D., 2005. Nav1.8 as a drug target for pain. In: COWARD,K. and BAKER,M.D., eds., Sodium channels, pain and analgesia Birkhäuser Publishing Ltd, Basel, CHE. 123-144

Content
NEBBIOSO, A., CLARKE, N., VOLTZ, E., GERMAIN, E., AMBROSINO, C., BONTEMPO, P., ALVAREZ, R., SCHIAVONE, E.M., FERRARA, F., BRESCIANI, F., WEISZ, A., DE LERA, A.R., GRONEMEYER, H. and ALTUCCI, L., 2005. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells Nature Medicine. 11(1), 77-84

Content
CLARKE, N., NEBBIOSO, A., ALTUCCI, L. and GRONEMEYER, H., 2005. TRAIL: at the center of drugable anti-tumor pathways Cell Cycle. 4(7), 914-918

Content
ALTUCCI, LUCIA, CLARKE, NICOLE, NEBBIOSO, ANGELA, SCOGNAMIGLIO, ANNAMARIA and GRONEMEYER, HINRICH, 2005. Acute myeloid leukemia: therapeutic impact of epigenetic drugs. International Journal of Biochemistry and Cell Biology. 37(9), 1752-62

Content
MULDER, KLAAS W, WINKLER, G SEBASTIAAN and TIMMERS, H TH MARC, 2005. DNA damage and replication stress induced transcription of RNR genes is dependent on the Ccr4-Not complex. Nucleic acids research. 33(19), 6384-92

Content
WINKLER, G SEBASTIAAN and TIMMERS, H TH MARC, 2005. Structure-based approaches to create new e2-e3 enzyme pairs. Methods in enzymology. 399, 355-66

Content
BOURQUE, E, KOCIENSKI, PJ, STOCKS, M and YUEN, J, 2005. Synthesis of the c14-c28 fragment of tetronasin Synthesis-Stuttgart. 3219-3224

Content
STOCKS, MJ, BARBER, S, FORD, R, LEROUX, F, ST-GALLAY, S, TEAGUE, S and XUE, YF, 2005. Structure-driven htl: Design and synthesis of novel aminoindazole inhibitors of c-jun n-terminal kinase activity Bioorganic & Medicinal Chemistry Letters. 15(14), 3459-3462

Content
FALSONE, S. F., GESSLBAUER, B., TIRK, F., PICCININI, A. M. and KUNGL, A. J., 2005. A proteomic snapshot of the human heat shock protein 90 interactome: FEBS Lett FEBS Lett. 579(28), 6350-4
Displaying 661 to 675 of 916
Previous … 43 44 45 46 47 … Next

School of Pharmacy

University of Nottingham
University Park
Nottingham, NG7 2RD

For all enquiries please visit:
www.nottingham.ac.uk/enquiry